Bioasis Technologies (FRA:107) EV-to-EBIT : -0.88 (As of Jun. 19, 2024)

Bioasis Technologies EV-to-EBIT Chart

Bioasis Technologies Annual Data
	Trend	Feb13	Feb14	Feb15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
EV-to-EBIT		Get a 7-Day Free Trial					-6.05	-4.91	-3.27	61.44	-5.42

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-EBIT	Get a 7-Day Free Trial															-5.55	-5.42	-5.03	-4.07	-4.70

Competitive Comparison of Bioasis Technologies's EV-to-EBIT

For the Biotechnology subindustry, Bioasis Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's EV-to-EBIT falls into.

Bioasis Technologies EV-to-EBIT Calculation

Bioasis Technologies's EV-to-EBIT for today is calculated as:

Bioasis Technologies's current Enterprise Value is €2.03 Mil.
Bioasis Technologies's EBIT for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies  (FRA:107) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bioasis Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2022 is calculated as:

Bioasis Technologies's Enterprise Value for the quarter that ended in Nov. 2022 was €9.84 Mil.
Bioasis Technologies's EBIT for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (FRA:107) Business Description